Is Crispr the Next Antibiotic?

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

By Knvul Sheikh For decades, scientists and doctors have treated common bacterial and viral infections with fairly blunt therapies. If you developed a sinus infection or a stomach bug, you would likely be given a broad-spectrum antibiotic that would clear...

Read More

TB Alliance & Macleods Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

Non-profit drug developer TB Alliance has granted Macleods Pharmaceuticals Limited a non-exclusive license to manufacture the anti-TB drug pretomanid as part of the three-drug “BPaL” regimen. Pending regulatory approvals, Macleods has agreed to commercialize the anti-tuberculosis (TB) medicine in approximately...

Read More

1st Pharmacy University of India DPSRU signs MoU with world’s first Pharmacy University CPU

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, the first Pharmacy University of India, has signed a Memorandum of Understanding with the world’s first Pharmacy University China Pharmaceutical University (CPU), Nanjing. The MoU was signed between the Vice Chancellor...

Read More

Takeda’s Dengue Vaccine Candidate Demonstrates Protection in Children Ages 4 to 16 Yrs

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of the ongoing pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial of its dengue vaccine candidate (TAK-003) were published in the New England Journal...

Read More

BIOGEN TO EXPAND BIOSIMILARS PORTFOLIO AND GAIN ACCESS TO ADDITIONAL MARKETS THROUGH NEW TRANSACTION

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

Biogen Inc. has announced a new proposed transaction with Samsung Bioepis Co., Ltd. to secure the exclusive rights to commercialize two new ophthalmology biosimilars, SB11 referencing Lucentis and SB15 referencing Eylea, in major markets worldwide, including the U.S., Canada, Europe,...

Read More

Strides announces relaunch of Ranitidine tablets (Rx) for the US Market

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

Strides Pharma Science Limited (Strides or company) has announced relaunch of Ranitidine tablets for the US market. USFDA had tested numerous ranitidine tablets on the market over the past few months and released a summary of the results on November...

Read More

Nearly 2000 additional pregnant women saved annually

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

“Maternal Mortality Ratio (MMR) of India has declined by 8 points in one year as per the latest Special Bulletin on MMR released by the Registrar General of India. This decline is important as it translates to nearly 2000 additional...

Read More

Cabinet approves MoUs signed between India & German Agency in field of Occupational Diseases

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

The Union Cabinet chaired by the Prime Minister Shri Narendra Modi has given ex-post facto approval for the MoUs between India and German for collaboration in the field of Occupational Diseases, Re-habilitation and vocational training of Insured Persons with disabilities....

Read More

Bilateral Discussions held with Minister of Food Safety, New Zealand

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

Shri. Ashwini Kumar Choubey, Minister of State for Health and Family Welfare and  Mr. Damien O’Connor, Minister of Agriculture, Minister for Biosecurity, Food Safety and Rural Communities and Minister of State for Trade and Export Growth Government of the New Zealand...

Read More

Zydus receives final approval from the USFDA for Cisatracurium Besylate Injection USP

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

Zydus Cadila has received the final approval from the USFDA to market Cisatracurium Besylate Injection USP 10 mg (base)/5 mL (2 mg/mL) and 200 mg (base)/20 mL (10 mg/mL) Single-Dose Vials (Preservative-free) (US RLD- Nimbex). This medication is used to...

Read More

FDA approves first therapy to treat patients with rare blood disorder

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

U.S. Food and Drug Administration granted approval to Reblozyl (luspatercept–aamt) for the treatment of anemia (lack of red blood cells) in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions. “When patients receive multiple blood transfusions,...

Read More

Delegation of Beijing Municipal Science & Technology Commission visits FDCA-Gujarat

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

“China Pharmaceuticals Industry Internationalization Strategy Summit and China-India Pharmaceutical Business Convention” at shanghai, China jointly organized by Shengjie, China and IPA, India during 16-17 May 2019 in which Punamchand K Parmar, a senior official in the Health and Family Welfare...

Read More

Every Licensed FBO declaration in Form IX compulsory

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

Every Licensed FBO declares in Form IX the particulars relating to the person in-charge of such establishment, branch, unit, with due certification that the concerned person has been so nominated for the purpose of compliance under FSS Act, Rules &...

Read More

Food safety check: Hotels, restaurants, canteens directed to have open kitchens

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

In the case of complaints of any kitchen compromising on hygiene standards, the violator will have to pay fine upto Rs 1 lakh The Gujarat government has directed restaurants, hotels and canteens to have open kitchens so that people can...

Read More

ABBOTT ANNOUNCES DISCOVERY OF NEW STRAIN OF HIV

  • accuprec_admin
  • Comments : 0
  • June 29, 2021

Abbott has announced that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L.1 The findings, published today in the Journal of Acquired Immune Deficiency Syndromes (JAIDS), show the...

Read More

Accreditations